ArticleVaccines2026
Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States.
Klodeta Kura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleVaccines2026
Klodeta Kura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.